The role of genetic variation near interferon-kappa in systemic lupus erythematosus

J Biomed Biotechnol. 2010:2010:706825. doi: 10.1155/2010/706825. Epub 2010 Jul 15.

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by increased type I interferons (IFNs) and multiorgan inflammation frequently targeting the skin. IFN-kappa is a type I IFN expressed in skin. A pooled genome-wide scan implicated the IFNK locus in SLE susceptibility. We studied IFNK single nucleotide polymorphisms (SNPs) in 3982 SLE cases and 4275 controls, composed of European (EA), African-American (AA), and Asian ancestry. rs12553951C was associated with SLE in EA males (odds ratio = 1.93, P = 2.5 x 10(-4)), but not females. Suggestive associations with skin phenotypes in EA and AA females were found, and these were also sex-specific. IFNK SNPs were associated with increased serum type I IFN in EA and AA SLE patients. Our data suggest a sex-dependent association between IFNK SNPs and SLE and skin phenotypes. The serum IFN association suggests that IFNK variants could influence type I IFN producing plasmacytoid dendritic cells in affected skin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Case-Control Studies
  • Chi-Square Distribution
  • Female
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Interferon Type I / genetics*
  • Linkage Disequilibrium
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / genetics*
  • Male
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Sex Factors
  • Skin Physiological Phenomena
  • Statistics, Nonparametric

Substances

  • Interferon Type I
  • interferon kappa

Grants and funding